Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Metalsguy1on Feb 13, 2022 6:30am
271 Views
Post# 34424003

RE:RE:RE:SVA, SPEC BUY, PT $3.25 Potential 100% increase.

RE:RE:RE:SVA, SPEC BUY, PT $3.25 Potential 100% increase.
It's great to see that we are getting some quality analysts and no longer subject to the drunken and delusional stylings of Doug Loe. The new analysts are not having much visible impact but maybe they will whenever the next substantial news hits. As to Doug Loe. His Linked In profile has a picture of him and his butt ugly kids - looks like they are on some expensive vacation. It is such a shame that he doesn't work under US jurisdiction. FiNRA and the SEC would be combing through his records like kids opening presents at Christmas. All the Canadian Authorities do is slap people on the wrist and say play nice an don't do that again - that is until they have managed to successfully bilk investors of millions. Let's see if Doug can grift his way through another news release when there are competing analysts of integrity now on board.
<< Previous
Bullboard Posts
Next >>